McKesson Corporation (MCK)
NYSE: MCK · IEX Real-Time Price · USD
580.13
+1.70 (0.29%)
At close: Jul 19, 2024, 4:00 PM
583.66
+3.53 (0.61%)
Pre-market: Jul 22, 2024, 7:31 AM EDT
McKesson Market Cap
McKesson has a market cap or net worth of $75.25 billion as of July 22, 2024. Its market cap has increased by 33.42% in one year.
Market Cap
75.25B
Enterprise Value
78.06B
1-Year Change
33.42%
Ranking
Category
Stock Price
$580.13
Market Cap Chart
Since December 1, 1998, McKesson's market cap has increased from $7.05B to $75.25B, an increase of 967.62%. That is a compound annual growth rate of 9.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 75.41B | 22.41% |
Dec 29, 2023 | 61.61B | 15.82% |
Dec 30, 2022 | 53.19B | 40.15% |
Dec 31, 2021 | 37.95B | 35.91% |
Dec 31, 2020 | 27.93B | 12.04% |
Dec 31, 2019 | 24.92B | 15.48% |
Dec 31, 2018 | 21.58B | -33.61% |
Dec 29, 2017 | 32.51B | 2.39% |
Dec 30, 2016 | 31.75B | -30.03% |
Dec 31, 2015 | 45.38B | -5.71% |
Dec 31, 2014 | 48.13B | 29.83% |
Dec 31, 2013 | 37.08B | 62.00% |
Dec 31, 2012 | 22.89B | 19.63% |
Dec 30, 2011 | 19.13B | 7.42% |
Dec 31, 2010 | 17.81B | 6.34% |
Dec 31, 2009 | 16.75B | 58.13% |
Dec 31, 2008 | 10.59B | -44.13% |
Dec 31, 2007 | 18.96B | 26.34% |
Dec 29, 2006 | 15.01B | -5.46% |
Dec 30, 2005 | 15.87B | 71.66% |
Dec 31, 2004 | 9.25B | -1.34% |
Dec 31, 2003 | 9.37B | 19.10% |
Dec 31, 2002 | 7.87B | -26.43% |
Dec 31, 2001 | 10.70B | 4.95% |
Dec 29, 2000 | 10.19B | 60.85% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Gilead Sciences | 90.40B |
Bristol-Myers Squibb Company | 86.44B |
HCA Healthcare | 84.38B |
Zoetis | 81.49B |
GSK | 80.24B |
CVS Health | 74.78B |
Becton, Dickinson and Company | 66.69B |
Edwards Lifesciences | 52.12B |